Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
PHASE1
This is a Phase 1, multi-center, open-label study with a dose-escalation ph...
A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)
PHASE1
The purpose of this research study is to see if a drug called LP-118 is saf...
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
PHASE1
The purpose of this study is to learn more about LP-118 (an experimental dr...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center